摘要
Abstract
Objective To summarize the situation of centralized drug procurement with volume(re-ferred to as centralized procurement)at the national and provincial levels,and provide suggestions for further optimizing the policy of centralized procurement policy.Methods The relevant database,the official websites of centralized drug and medical equipment procurement platforms,as well as the medical security administra-tions,of provinces,autonomous regions,municipalities directly under the central government,and the Xinjiang Production and Construction Corps[hereinafter referred to as provinces(autonomous regions,municipalities,and the Corps)]were retrieved.The documents such as the published implementation plan of centralized drug procurement,the procurement announcement,and the notification of winning results issued from March 2019 to September 2024 were collected.The number of drug varieties,treatment fields and dosage forms,develop-ment forms and evaluation modes of centralized procurement drug were compared and analyzed.Results By September 2024,a total of nine batches of ten rounds of national centralized procurement had included 374 va-rieties,and the average number of varieties collected by provinces alone and/or in alliance reached 341.Among the 31 provinces(autonomous regions,municipalities,and the Corps),25 provinces(autonomous regions,mu-nicipalities,and the Corps)had exceeded the planned target of"180 varieties at the provincial level"in ad-vance,and 28 provinces(autonomous regions,municipalities,and the Corps)had exceeded the planned target of"500 varieties at the national+provincial level"in advance.The centralized drug procurement organized by the state and local governments involved 374 and 1098 varieties of drugs,respectively.Up to now,the national centralized procurement of eight batches of chemical drugs had been carried out,covering 218 varieties,and one batch of biological drugs has been carried out,covering 16 kinds of insulin.A total of 31 provinces(autono-mous regions,municipalities,and the Corps)across the country participated in the inter-provincial alliance centralized procurement.A total of 26 provincial or provincial alliances adopted the comprehensive evaluation mode,of which 65%of the prices of centralized procurement accounted for 50%or more,while the inter-pro-vincial alliance of eight provinces and two regions,the alliance of 11 provinces in Shaanxi,and Heilongjiang Province accounted for 70%or more.Conclusion It is suggested that the selected varieties of centralized pro-curement should be selected as the optimal selection,while retaining the non-selected original drug selection channel with sufficient evidence-based evidence;real-world clinical research on selected varieties in centralized procurement should be conducted actively,the promotion and information disclosure of generic drug knowl-edge should be strengthened;the accuracy of centralized procurement declaration quantity of medical institu-tions should be improved,and the supply capacity of the selected enterprises should be evaluated;the compre-hensive evaluation mode of centralized purchase should be optimized,and the multi-dimensional factors such as economy,quality and supply of the selected varieties should be considered comprehensively and balanced.关键词
药品/集中带量采购/综合评价Key words
Drugs/Centralized procurement with volume/Comprehensive evaluation分类
医药卫生
